1. Home
  2. SENS vs ARMP Comparison

SENS vs ARMP Comparison

Compare SENS & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$8.33

Market Cap

308.5M

Sector

Industrials

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$10.93

Market Cap

296.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SENS
ARMP
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.5M
296.7M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
SENS
ARMP
Price
$8.33
$10.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$25.58
$15.00
AVG Volume (30 Days)
464.3K
49.7K
Earning Date
04-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.40
EPS
N/A
N/A
Revenue
$16,389,000.00
N/A
Revenue This Year
$59.55
N/A
Revenue Next Year
$69.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.41
$0.90
52 Week High
$8.75
$13.75

Technical Indicators

Market Signals
Indicator
SENS
ARMP
Relative Strength Index (RSI) 63.80 71.26
Support Level $7.35 $5.14
Resistance Level $8.74 $13.75
Average True Range (ATR) 0.50 0.89
MACD 0.02 0.26
Stochastic Oscillator 75.00 78.58

Price Performance

Historical Comparison
SENS
ARMP

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: